Gollob Jared

EDGAR CIK 0001821198

Kymera Therapeutics, Inc. - KYMR

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
Chief Medical Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($139,967)
-3,344 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/04/2024
03/04/2024
Sell
-3,344 @ $41.86
 ($139,967) 95,740 (-3.37%) Direct